Likewise, hyper-O-GlcNAcylation induced by OGA inhibition was found to sensitize bortezomib-induced apoptosis and reverse bortezomib resistance in mantle cell lymphoma (MCL), suggesting the potential utility of OGA inhibitors such as ketoconazole in adjuvant therapy of MCL [50]. The gene discussed is OGA; the disease is mantle cell lymphoma.